Resection for Multiple Hepatocellular Carcinomas (HCC)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Prof. Guido Torzilli, University of Milan
ClinicalTrials.gov Identifier:
NCT01387061
First received: June 29, 2011
Last updated: September 18, 2011
Last verified: September 2011

June 29, 2011
September 18, 2011
June 2001
June 2011   (final data collection date for primary outcome measure)
Overall survival plus multivariate analysis [ Time Frame: 10 years ] [ Designated as safety issue: No ]
The primary endpoint of the study was the overall survival of patients resected for multiple HCC, and the univariate and multivariate analyses of prognostic factors for overall survival.
Same as current
Complete list of historical versions of study NCT01387061 on ClinicalTrials.gov Archive Site
Disease-free survival [ Time Frame: 10 years ] [ Designated as safety issue: No ]
The secondary endpoint was the disease-free survival.
Same as current
Not Provided
Not Provided
 
Resection for Multiple Hepatocellular Carcinomas (HCC)
Hepatic Resection for Multiple Hepatocellular Carcinoma on Cirrhosis

Surgical resection in patients with multiple hepatocellular carcinomas (HCC) remains controversial. The aim of this study was to investigate the outcome of a consecutive cohort of patients resected for multiple HCC, without macrovascular invasion, in order to identify clinically reliable parameters to select patients for surgery.

Not Provided
Interventional
Not Provided
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
  • Hepatocellular Carcinoma
  • Multiple Tumors
  • Cirrhosis
Procedure: hepatic resection
surgical resection of the liver for multiple HCC
Experimental: hepatic resection
Intervention: Procedure: hepatic resection
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
87
June 2011
June 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • patients with multiple HCC without macrovascular invasion on liver cirrhosis

Exclusion Criteria:

  • macrovascular invasion;
  • normal liver;
  • distant or lymphnodes metastasis
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
Italy
 
NCT01387061
multipleHCC
Not Provided
Prof. Guido Torzilli, University of Milan
University of Milan
Not Provided
Study Chair: Guido Torzilli, MD, PhD University of Milan
University of Milan
September 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP